This announcement is a separate document:
サンバイオ：[遅れました] SB623慢性外傷性の製造および販売承認の状況に関するさらなる最新情報
SanBio: [Delayed] Further Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.